Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
April 27, 2007

Wyeth Sells 10 Drugs for Almost $76.5M

  • Meda purchased 10 European on-market drugs from Wyeth for SEK 525 million, or approximately $76.49 million.

    Meda expects the products to add about SEK 160-170 million, or between $23 million and $25.41 million, in sales into its operation for the rest of 2007. It reports that the acquisition enhances its position in two of its most important markets, Italy and France. These countries account for about 60% of the acquired products' sales, according to the company.

    Meda states that the biggest product acquired through this deal is Seresta®, an anti-anxiety agent used for sleep disorders and various substance-withdrawal syndromes.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.